Similarly, melatonin acts as an inhibitor of the immunoproteasome, stabilizing ATRAP levels and alleviating Ang II-induced AF along with associated pathological changes such as fibrosis, inflammation, and oxidative stress [118]. The gene discussed is AGT; the disease is atrial fibrillation.